APLS - Apellis Pharmaceuticals, Inc. - Insider Stock Trading

Filing Date	T Date	Ticker	Sector	Ind	Industry	Owner	oSt	Rel	Title	#f	T	TVal	Price	Qty	Own	H
10/23/25 16:20	10/21/25	APLS	Health	Drug	Pharmaceutical Preparations	Sullivan Timothy Eugene	MA	O	CFO	6	S.d	-1,695	28.12	-60	203	D
10/17/25 16:15	10/16/25	APLS	Health	Drug	Pharmaceutical Preparations	Watson David O.	MA	O	GC	12	S	-1,743	26.11	-67	228	D
10/15/25 20:12	10/10/25	APLS	Health	Drug	Pharmaceutical Preparations	Dunlop A. Sinclair	MA	D		5	S	-4,946	29.57	-167	302	M
9/17/25 20:08	9/15/25	APLS	Health	Drug	Pharmaceutical Preparations	Chopas James George	MA	O	VP,Chief	8	S	-130	30.64	-4	54	D
8/29/25 16:19	8/27/25	APLS	Health	Drug	Pharmaceutical Preparations	Francois Cedric	MA	DO	CEO	7	S.dm	-10,420	25.25	-413	1,971	I
2/12/25 13:59	2/11/25	APLS	Health	Drug	Pharmaceutical Preparations	Delong Mark Jeffrey	MA	O	Chief Bu	5	S	-147	29.55	-5	86	D
1/30/25 12:18	1/29/25	APLS	Health	Drug	Pharmaceutical Preparations	Townsend Adam J.	MA	O	Chief Co	4	S	-265	29.72	-9	90	D
1/30/25 12:13	1/29/25	APLS	Health	Drug	Pharmaceutical Preparations	Nicholson Nur	MA	O	Chief Te	4	S	-284	29.77	-10	88	D
1/30/25 12:12	1/29/25	APLS	Health	Drug	Pharmaceutical Preparations	Lewis Karen	MA	O	Chief Pe	4	S	-147	29.69	-5	72	D
1/30/25 12:10	1/29/25	APLS	Health	Drug	Pharmaceutical Preparations	Eisele Jeffrey	MA	O	Chief De	4	S	-57	30.14	-2	57	D
1/30/25 12:07	1/29/25	APLS	Health	Drug	Pharmaceutical Preparations	Deschatelets Pascal	MA	O	Chief Sc	4	S	-233	29.78	-8	1,152	D
1/21/25 15:54	1/17/25	APLS	Health	Drug	Pharmaceutical Preparations	Baumal Caroline	MA	O	Chief Me	2	S	-151	32.28	-5	93	D

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person